Nitraria retusa fruit aqueous extract Pretreatment for 6 days and treatment during penconazole exposure 300 mg/kg b.w., p.o., daily Male Wistar rats about 250 g
A fungicide penconazole-induced kidney injury 67 mg/kg b.w. (1/30 LD50) i.p., every 2 days from 7th until 15th day Plasma: GGT, ALP ↓; CR, urea, UA, LDH ↑ Urine: volume ↑, CR, urea, UA ↓ Kidney: LDH, MDA, H2O2, PC, AOPP, NP-SH, GSH, MT, CAT, SOD, GPx ↑ Kidney: enlarged Bowman’s space, necrosis of the epithelial cells lining the tubules, infiltration of leucocytes, glomeruli fragmentation ↑
Plasma: ALP (+), urea, LDH, GGT (++), CR, UA (+++) Urea: UA (+), volume, CR, urea (++) Kidney: LDH, MDA, H2O2, PC, AOPP, NP-SH, GSH, CAT, SOD, GPx (++), MT (+++) Kidney: necrosis of the epithelial cells lining the tubules (++), enlarged Bowman’s space, infiltration of leucocytes, glomeruli fragmentation (+++)
Standardized Tribulus Terrestris extract tablets 1000 mg (min. 45% saponins) Now Sports Co. (USA) 5 or 10 mg/kg daily, p.o., for 17 days Male Swiss albino mice, 20-28 g
A pesticide rotenone-induced parkinsonism, nine doses of 1 mg/kg given each , s.c. Activity index (18th day) ↓ Substantia nigra: % of pycnotic neurons ↑, % of viable neurons ↓ Striatum: relative expression of iNOS, COX-2 and MTH 1, MDA, 8-OH-dG ↑, dopamine, GSH, SOD, CAT ↓
Activity index (18th day) (+ 5, +++ 10) Substantia nigra: % of viable neurons (+ 50, +++ 10), % of pycnotic neurons (++ 5, +++ 10) Striatum: GSH, SOD, MDA (0 5, ++ 10), CAT (0 5, +++ 10), dopamine (+ 5, ++ 10), relative expression of COX-2 and iNOS (++ both doses), 8-OH-dG and relative expression of MTH 1 (++ 5, +++ 10)
Punica granatum L. pomegranate peel methanol extract 250 mg/kg daily, i.g., for 4 weeks Male Wistar rats, 140-160 g
Gibberellic acid-3 (a plant growth regulator) 20 mg/kg i.g., daily for 4 weeks Testes: area percent of androgen receptor immunoreaction, SOD, CAT ↓
Testes: area percent of androgen receptor immunoreaction, SOD, CAT (+++)
None
↓: a decrease vs. control; ↑: an increase vs. control; (+): a slight beneficial effect; (++): a distinct beneficial effect; (+++): a complete beneficial effect; (0): no beneficial effect.